BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11846025)

  • 1. Regulation of cyclin-Cdk activity in mammalian cells.
    Obaya AJ; Sedivy JM
    Cell Mol Life Sci; 2002 Jan; 59(1):126-42. PubMed ID: 11846025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
    Hengst L; Göpfert U; Lashuel HA; Reed SI
    Genes Dev; 1998 Dec; 12(24):3882-8. PubMed ID: 9869641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
    J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cyclin-dependent kinases in Arabidopsis thaliana.
    Stals H; Casteels P; Van Montagu M; Inzé D
    Plant Mol Biol; 2000 Aug; 43(5-6):583-93. PubMed ID: 11089862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of CDK/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression.
    Loyer P; Trembley JH
    Semin Cell Dev Biol; 2020 Nov; 107():36-45. PubMed ID: 32446654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.
    Ekholm SV; Reed SI
    Curr Opin Cell Biol; 2000 Dec; 12(6):676-84. PubMed ID: 11063931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of rat postnatal lung alveolar development by glucocorticoids: involvement of the p21CIP1 and p27KIP1 cyclin-dependent kinase inhibitors.
    Corroyer S; Schittny JC; Djonov V; Burri PH; Clement A
    Pediatr Res; 2002 Feb; 51(2):169-76. PubMed ID: 11809910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G1 cyclin/cyclin-dependent kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression.
    Calbó J; Parreño M; Sotillo E; Yong T; Mazo A; Garriga J; Grana X
    J Biol Chem; 2002 Dec; 277(52):50263-74. PubMed ID: 12401786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
    Klein MA
    Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors.
    Brooks G; Poolman RA; Li JM
    Cardiovasc Res; 1998 Aug; 39(2):301-11. PubMed ID: 9798515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of Cyclin-Dependent Kinase Fusion Complexes for In Vitro Analysis.
    Kõivomägi M
    Methods Mol Biol; 2021; 2329():95-109. PubMed ID: 34085218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways that control cell proliferation.
    Duronio RJ; Xiong Y
    Cold Spring Harb Perspect Biol; 2013 Mar; 5(3):a008904. PubMed ID: 23457258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
    Rideout HJ; Wang Q; Park DS; Stefanis L
    J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.